• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

AmeriCann Adds R&D Facility to Massachusetts Project Plans

AmeriCann, Inc. (OTC:ACAN) will be adding a 30,000 square foot research and development facility to their already planned Freetown, Massachusetts cannabis cultivation and processing facility.

 

Massachusetts Medical Cannabis Center

 

AmeriCann's newest cultivation and processing property that they are developing is called the Massachusetts Medical Cannabis Center. Located in Freetown, MA, the town's planning board already unanimously approved a 1 million square foot plan on December 8th. 

 

Last night, the Freetown Planning Board unanimously approved an expanded plan to include a new 30,000 square foot R&D facility. This R&D facility will be in addition to the approved first phase 130,000 square foot cultivation and processing build, making for expanded capacity for 2017 tenants. 

 

According to the release, the Massachusetts Medical Cannabis Center "is expected to be one of the largest and most technologically advanced cannabis cultivation facilities in the nation." The facility will be built on the over 50 acre property that ACAN purchased from Boston Beer Company (NYSE:SAM) back in October for $4,475,000. 

 

CEO Praise


"We are pleased that Freetown has approved the expansion of our plans to include a cannabis research and product center in the first phase," stated Tim Keogh, CEO of AmeriCann. "The goal is to make MMCC the place in the northeast U.S. for the creation of a wide variety of exciting new advanced products for medical cannabis patients."

 

Conclusion

 

For more recent coverage and news on AmeriCann. Inc. be sure to check out ACAN's stock profile in our marijuana stocks database. Also, don't forget to connect with The Daily Marijuana Observer on social media using the links to the right of this article. 

 

Read more articles tagged:

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.